|
US2021008190A1
|
|
Methods and agents including STING agonist to treat tumor
|
|
US2020306369A1
|
|
Methods and reagents to treat allergy
|
|
US2020306536A1
|
|
Method and device for improving brain function
|
|
US2020010530A1
|
|
Methods and reagents to treat autoimmune diseases and allergy
|
|
CN111918668A
|
|
Methods and agents for treating tumor cells and cancer
|
|
US2019160174A1
|
|
Methods and agents to treat tumor cells and cancer
|
|
US2018271997A1
|
|
Methods and Reagents to Treat Tumor and Cancer
|
|
WO2018231661A1
|
|
Methods and reagents to treat tumor and cancer
|
|
US2018296850A1
|
|
Reagents and methods for cancer treatment using Magnetic particle
|
|
US2018311335A1
|
|
Cell surface anchoring antigen conjugates to treat cancer
|
|
US2018071269A1
|
|
Therapeutical methods, formulations and nutraceutical formulations
|
|
CN110022886A
|
|
A kind of method and reagent for treating autoimmune disease and allergy
|
|
US2017165334A1
|
|
Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
|
|
US2017212128A1
|
|
Methods and compositions for mass spectrometry analysis
|
|
CN108431018A
|
|
The method of protein modification in medicinal application
|
|
CN106659755A
|
|
Methods, drugs and drug formula for processing mammal sexual dysfunction
|
|
US2016033497A1
|
|
Luminescence methods and reagents for analyte detection
|
|
US2013131423A1
|
|
Methods to detect and treat diseases
|
|
CN103732271A
|
|
Method and device to detect and treat diseases such as tumor or virus infection
|
|
US2012208295A1
|
|
Methods and compositions for mass spectrometry analysis
|
